{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T08:24:24Z","timestamp":1750494264311},"reference-count":11,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PPA"],"DOI":"10.2147\/ppa.s310086","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T01:37:31Z","timestamp":1624930651000},"page":"1469-1476","source":"Crossref","is-referenced-by-count":1,"title":["Usability of the Certolizumab Pegol Auto-Injection Device in Australian Patients with Chronic Rheumatic Diseases: Results from a Market Research Study"],"prefix":"10.2147","volume":"Volume 15","author":[{"given":"Juan","family":"Aw","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hedley","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Zochling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred","family":"Lanzafame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s40267-017-0446-2","volume":"33","author":"Lyseng-Williamson","year":"2017","journal-title":"Drugs Ther Perspect"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/rheumatology\/ket409","volume":"53","author":"Hyrich","year":"2014","journal-title":"Rheumatology"},{"key":"ref3","unstructured":"Cimzia\u00ae. (Certolizumab Pegol) 200 Mg\/Ml Injection [Australian Prescribing Information]. Malvern: UCB Pharma; 2019."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2217\/ijr.15.39","volume":"10","author":"Marengo","year":"2015","journal-title":"Int J Clin Rheumtol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1080\/10717544.2019.1587043","volume":"26","author":"van den Bemt","year":"2019","journal-title":"Drug Delivery"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1007\/s12325-020-01257-6","volume":"37","author":"Bailey","year":"2020","journal-title":"Adv Ther"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s12325-017-0645-1","volume":"35","author":"Doma\u0144ska","year":"2018","journal-title":"Adv Ther"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/17425247.2016.1256283","volume":"14","author":"Doma\u0144ska","year":"2017","journal-title":"Expert Opin Drug Deliv"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1477-7525-9-2","volume":"9","author":"Keininger","year":"2011","journal-title":"Health Qual Life Outcomes"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s40744-017-0080-4","volume":"4","author":"Schiff","year":"2017","journal-title":"Rheumatol Ther"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s12325-018-0759-0","volume":"35","author":"Maniadakis","year":"2018","journal-title":"Adv Ther"}],"container-title":["Patient Preference and Adherence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=71116","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=71116","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T01:37:42Z","timestamp":1624930662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/usability-of-the-certolizumab-pegol-auto-injection-device-in-australia-peer-reviewed-fulltext-article-PPA"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":11,"URL":"https:\/\/doi.org\/10.2147\/ppa.s310086","relation":{},"ISSN":["1177-889X"],"issn-type":[{"value":"1177-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6]]}}}